Pages that link to "Q33864915"
Jump to navigation
Jump to search
The following pages link to Nanoscale strategies: treatment for peripheral vascular disease and critical limb ischemia. (Q33864915):
Displaying 11 items.
- Biomaterials and Nanotherapeutics for Enhancing Skin Wound Healing (Q28077978) (← links)
- Neuropeptide Y3-36 incorporated into PVAX nanoparticle improves functional blood flow in a murine model of hind limb ischemia (Q36311441) (← links)
- Characterizing nanoscale topography of the aortic heart valve basement membrane for tissue engineering heart valve scaffold design (Q36763926) (← links)
- Accelerated Blood Clearance Phenomenon Reduces the Passive Targeting of PEGylated Nanoparticles in Peripheral Arterial Disease (Q37123107) (← links)
- Current Phase II drugs under investigation for the treatment of limb ischemia (Q38571123) (← links)
- Gene-based therapies in patients with critical limb ischemia. (Q38764506) (← links)
- Re-assessing the enhanced permeability and retention effect in peripheral arterial disease using radiolabeled long circulating nanoparticles (Q38859160) (← links)
- Multifunctional Transmembrane Protein Ligands for Cell-Specific Targeting of Plasma Membrane-Derived Vesicles (Q41098832) (← links)
- Design and characterization of hydrogel nanoparticles with tunable network characteristics for sustained release of a VEGF-mimetic peptide (Q47880097) (← links)
- A non-sacrificial method for the quantification of poly(ethylene glycol) grafting density on gold nanoparticles for applications in nanomedicine (Q92181134) (← links)
- Administration of Slow-Release Synthetic Prostacyclin Agonist Promoted Angiogenesis and Skeletal Muscle Regeneration for Limb Ischemia (Q97423824) (← links)